Worth reading
51Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
37600
unitsWording
Conditional
How definitive the wording is.Details of issuance or disposal
Acquisition and cancellation of stock acquisition rights with an exercise price adjustment clause, and report on monthly exercise status
Intended allottee
EVO FUND (existing allottee)
発行済株式総数
0.0% (exercise ratio for the relevant month)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥107 (on each exercise date during the relevant month; no exercises) / Details of the adjustment clause and its lower limit: Not disclosed
Number of Stock Acquisition Rights
Total issued: 82,700 units; exercised: 45,100 units; acquired and cancelled: 37,600 units; remaining after cancellation: 0 units. Exercised during the relevant month: 0 units
Most recent equity financing
Timing 13 February 2026 / Type Issuance of the 10th Series of Stock Acquisition Rights (with an Exercise Price Adjustment Clause) through a third-party allotment / Amount Not disclosed
Impact on Business Performance
The company expects the impact on its consolidated results for the fiscal year ending December 2026 to be immaterial
| Item | Details |
|---|---|
| Type of issuance or disposal | Acquisition and cancellation of stock acquisition rights with an exercise price adjustment clause, and report on monthly exercise status |
| Intended allottee | EVO FUND (existing allottee) |
| Dilution Rate | 0.0% (exercise ratio for the relevant month) |
| Total number of issued shares | 16,778,500 shares (as of the end of the preceding month) → Not disclosed |
| Exercise price | ¥107 (on each exercise date during the relevant month; no exercises) / Details of the adjustment clause and its lower limit: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 82,700 units; exercised: 45,100 units; acquired and cancelled: 37,600 units; remaining after cancellation: 0 units. Exercised during the relevant month: 0 units |
| Most recent equity financing | Timing 13 February 2026 / Type Issuance of the 10th Series of Stock Acquisition Rights (with an Exercise Price Adjustment Clause) through a third-party allotment / Amount Not disclosed |
| Impact on Business Performance | The company expects the impact on its consolidated results for the fiscal year ending December 2026 to be immaterial |
Items this document does not state (20)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company expects the impact of this matter on its consolidated results for the fiscal year ending December 2026 to be immaterial.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.